Drugs / γδ T cells
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 04 trials | ||||||
| Phase 0 | NCT07123662 | Sep 2025 → May 2028 | myeloid leukemia | Guangzhou Bio-gene Technology Co., Ltd | Withdrawn | No outcome recorded |
| Phase 0 | NCT06364800 | Apr 2024 → Apr 2026 overdue | hepatocellular carcinoma | Beijing 302 Hospital | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT04439721 | May 2020 → May 2021 | lymphoid leukemia | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Unknown | No outcome recorded |
| Phase 0 | NCT03113058 | May 2017 → Oct 2018 | — | Jinan University Guangzhou | Unknown | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT06196294 | May 2024 → Nov 2030 expected | liver cancer, lung cancer, malignant pancreatic neoplasm, mesothelioma | Second Affiliated Hospital of Guangzhou Medical University | Recruiting | No outcome recorded |
| Phase 1 | NCT06364787 | Apr 2024 → Apr 2026 overdue | hepatocellular carcinoma | Beijing 302 Hospital | Not yet recruiting | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT03183206 | Jun 2017 → Jun 2018 | breast cancer | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT03180437 | Jun 2017 → Jun 2018 | malignant pancreatic neoplasm | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT02425748 | Jun → Dec 2017 | lung cancer | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT02425735 | Apr 2015 → Jun 2016 | hepatocellular carcinoma | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | γδT cells | “Collect blood from the patients and isolate mononuclear cells, select and grow γδT cells and transfect the γδT cells with GPC3 or Mesothelin targeting CAR” NCT06196294 ↗9“γδ T cells will be used against non small lung tumor.” NCT02425748 ↗ “Peripheral intravenous infusion of γδ T cells” NCT07123662 ↗ “infusion of donor γδT cells” NCT04439721 ↗ |
| Modality | Cell therapy | “γδ T cell-based immunotherapy for CCA.” PMID 30736852 ↗ Feb 2019 |
| Route | Intravenous | “via intravenous infusion of in vitro-activated allogeneic γδ Tcells” NCT03113058 ↗ |